In this issue:
The NSAID-IBD exacerbation association
Significance of diagnosis and prognosis for AOI in UC
Comorbidity influences biologic safety in older adults with IBD
Infliximab and corticosteroids for checkpoint inhibitor-induced colitis
Obefazimod for moderate-tosevere active UC
IBD-associated CRC: epidemiology and outcomes
FMT + anti-inflammatory diet in mild-to-moderate UC
Adrenomedullin for biologicresistant CD
Early anti-TNF initiation in IBDs
Long-term outcomes with darvadstrocel in perianal fistulising CD
Please login below to download this issue (PDF)